Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of NCOA4 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of NCOA4 mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of NCOA4 mRNA | increases expression | 18648102
|
C109238 |
acyline |
acyline results in decreased expression of NCOA4 mRNA | decreases expression | 17510436
|
D013196 |
Dihydrotestosterone |
NCOA4 protein promotes the reaction [Dihydrotestosterone results in increased activity of AR protein] | increases activity|increases reaction | 19815066
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of NCOA4 mRNA | increases expression | 20458559
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of NCOA4 mRNA | affects expression | 17331233
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NCOA4 mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of NCOA4 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of NCOA4 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCOA4 mRNA | affects cotreatment|increases expression | 17942748
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NCOA4 mRNA | affects cotreatment|increases expression | 17183730
|
C029938 |
nickel sulfate |
nickel sulfate results in decreased expression of NCOA4 mRNA | decreases expression | 16780908
|
D011374 |
Progesterone |
Progesterone results in decreased expression of NCOA4 mRNA | decreases expression | 18037150
|
D020849 |
Raloxifene |
Raloxifene affects the expression of NCOA4 mRNA | affects expression | 14699072
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR2 protein] results in decreased expression of NCOA4 mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of NCOA4 mRNA | affects expression | 14699072
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR2 protein] results in decreased expression of NCOA4 mRNA | affects cotreatment|decreases expression | 19059307
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of NCOA4 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NCOA4 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of NCOA4 mRNA | increases expression | 17942748
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of NCOA4 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.58 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.38 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
8.38 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.93 | 19490988 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
4.31 | 19131640 16100012 11954676 12718980 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.29 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.29 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.75 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.40 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.60 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.54 | 15800139 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.26 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.95 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.57 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.48 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.66 | 15885639 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.00 | 20603192 18985861 18775368 17157402 19460635 17507914 19232924 18316065 15238991 18558336 18940202 18177632 18396377 17688650 16609825 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.05 | 11289319 1440618 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.08 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
8.98 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.98 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
8.03 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
8.03 | 8888407 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.37 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
11.01 | 15665606 15845082 15380490 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
11.01 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
1.96 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
1.96 | 17242785 15775269 17440819 15572757 17049068 17893378 17952589 16912660 16837676 15758505 17595753 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.96 | 19066611 20135344 17049068 19189210 19244106 15565566 16818667 18855134 19487384 18629630 20859285 19103187 19221464 19155303 17440819 15668708 20005174 19059307 17893378 16273361 17261762 19084267 19288272 16202921 18425577 20544844 20390343 19142967 18821012 19115204 18997820 18351453 19011961 11161223 20065188 19189212 19289846 18984771 17242785 19410462 21138602 21152245 16873071 18815881 19200415 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.96 | 20435547 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.34 | 11589617 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.80 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.52 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
8.88 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.88 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.88 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
8.88 | 14691202 15553829 16217749 15073043 11135700 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
8.88 | 16924424 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.90 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.68 | 7296757 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.12 | 12490120 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.51 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.51 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 18670907 18850075 16120746 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.45 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
11.15 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.15 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.15 | 12371664 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.71 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.40 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.40 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.40 | 17333356 16105132 16919318 15861022 17681005 17110522 11677210 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 15340226 16354765 8697196 12621046 15668235 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.63 | 15800139 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.19 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
3.77 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.77 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.77 | 8888407 17688650 16575769 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
10.94 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
10.94 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.10 | 15213294 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.38 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.16 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
7.19 | 8156756 18759878 12868966 14531868 11906362 8970840 11298694 2524372 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
7.19 | 16780908 16823706 11298694 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.50 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
9.04 | 17451421 15920148 17308373 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
9.04 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.51 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
12.03 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
12.03 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
12.03 | 18692083 9328219 16192314 9653073 8291058 6679447 18289764 18648102 6482804 1440618 7440962 11289319 9022650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.03 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.03 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.06 | 1851702 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.87 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.87 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
22.03 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
22.03 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
22.03 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
22.03 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.05 | 19155303 17893378 16202921 20544844 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.94 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.94 | 9294722 10568697 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.17 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.95 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.94 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.59 | 6426943 6254150 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.31 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.08 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.47 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.47 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
30.84 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
30.84 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
30.84 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
30.84 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
30.84 | 19224547 14986274 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
30.84 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.24 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.92 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.14 | 18558336 8888407 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.05 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.55 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.20 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.53 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.53 | 20067830 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.27 | 16904648 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.24 | 8708960 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.04 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.33 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.54 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.44 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.52 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.91 | 12621046 15340226 16120746 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.89 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 8697196 15340226 16959395 18606429 16354765 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.95 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.59 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.59 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.59 | 18850075 18670907 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
4.64 | 16612254 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
4.41 | 15869954 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.49 | 17937319 |
MESH:D007249 |
Inflammation |
|
Progesterone |
8.31 | 15869954 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
8.31 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.31 | 12200463 12878042 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.05 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.47 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.34 | 18776723 10903974 8314463 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
23.37 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
23.37 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
23.37 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
23.37 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
23.37 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.50 | 16973256 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.83 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.80 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.33 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.43 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.76 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
3.91 | 16467208 16968895 19850784 20471514 17050201 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.91 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.22 | 16891316 12018890 15213294 17869043 15336539 11161223 16112521 16823087 19075265 19225113 19035177 12679006 17712046 16966277 11468182 17217047 17107899 16330433 16331271 15622746 12712474 17649720 15748426 19642359 9834237 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.36 | 16882451 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.16 | 17567588 15342952 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.20 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.28 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.70 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
10.70 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
10.70 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.70 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
14.12 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
14.12 | 598648 6587162 3712494 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
14.12 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.12 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.35 | 15213294 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.29 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.04 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
3.38 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.38 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.38 | 19555203 11884234 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.78 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
6.09 | 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.09 | 14580682 11731420 19196723 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.58 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.88 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.20 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.18 | 16166281 16966607 18303189 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.82 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.19 | 18803445 18765137 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.58 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
7.42 | 14977855 19417148 15949261 19549372 11468182 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
7.42 | 16497877 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.03 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.70 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.42 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.42 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.58 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
10.41 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
10.41 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.97 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.70 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.70 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.03 | 19196722 19200415 19189210 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.47 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.29 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.22 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
12.15 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
12.15 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
12.15 | 16359493 8888407 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
15.09 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
15.09 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
15.09 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.05 | 3988306 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.39 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.23 | 17893378 17823083 15758505 15579764 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
4.94 | 12452020 16624393 19769630 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
4.94 | 17393432 16525653 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
2.52 | 15580305 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.50 | 7296757 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.17 | 19927285 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.50 | 6228378 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.91 | 10923243 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.22 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.53 | 11896295 11399792 11118676 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.53 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.62 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.62 | 16220300 15731164 16536755 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.62 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 16919318 15861022 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.57 | 11422049 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.23 | 16882103 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.03 | 17322281 17975199 17365031 15814490 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.58 | 15770314 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.38 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.18 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.86 | 18045962 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.97 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.07 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
9.83 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
9.83 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
9.83 | 1511512 15475178 3137016 16876388 11044598 14763951 17978042 11738929 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.04 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.66 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.66 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
10.94 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
10.94 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.78 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.57 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
1.86 | 17007042 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.82 | 16837676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
OMIM:188550 |
THYROID CARCINOMA, PAPILLARY |
marker/mechanism |
|
| |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.16 | 6582329 3712494 1399818 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
7.16 | 19014326 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.24 | 19048282 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.98 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.26 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.54 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
19.91 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
19.91 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
19.91 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
19.91 | 11780464 20435036 12973940 12845720 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
19.91 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
19.91 | 17572228 16712894 8653321 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.66 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
12.06 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
12.06 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.01 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.24 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 14671159 15869587 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.58 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.47 | 17120751 |